Synjardy (Boehringer Ingelheim Pharmaceuticals, Inc.)
Welcome to the PulseAid listing for the Synjardy drug offered from Boehringer Ingelheim Pharmaceuticals, Inc.. This Sodium-Glucose Cotransporter 2 Inhibitor [EPC],Sodium-Glucose Transporter 2 Inhibitors [MoA],Biguanide [EPC],Biguanides [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Boehringer Ingelheim Pharmaceuticals, Inc. |
| NON-PROPRIETARY NAME: | empagliflozin and metformin hydrochloride |
| SUBSTANCE NAME: | EMPAGLIFLOZIN; METFORMIN HYDROCHLORIDE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Sodium-Glucose Cotransporter 2 Inhibitor [EPC],Sodium-Glucose Transporter 2 Inhibitors [MoA],Biguanide [EPC],Biguanides [Chemical/Ingredient] |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2015-08-26 |
| END MARKETING DATE: | 0000-00-00 |
Synjardy HUMAN PRESCRIPTION DRUG Details:
| Item Description | Synjardy from Boehringer Ingelheim Pharmaceuticals, Inc. |
| LABELER NAME: | Boehringer Ingelheim Pharmaceuticals, Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 5; 500(mg/1; mg/1) |
| START MARKETING DATE: | 2015-08-26 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0597-0159_7256bf23-1d38-b70e-0595-365636a220a4 |
| PRODUCT NDC: | 0597-0159 |
| APPLICATION NUMBER: | NDA206111 |
Other EMPAGLIFLOZIN; METFORMIN HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers:
